Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $42.33 Average PT from Analysts
Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) has received a consensus rating of “Buy” from the six ratings firms that are currently covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have updated their coverage on the stock in […]
More Stories
US Embassy Warns Americans to Reconsider Travel to Saudi Arabia Amid Houthi Strikes
By Jack Phillips The U.S. Embassy in Saudi Arabia’s capital on Tuesday issued renewed warnings about traveling to the country...
Pope Leo XIV Diagnosed With Cancer as Doctors Remove Part of His Lung
By Jill McLaughlin Pope Leo XIV was diagnosed with lung cancer following surgery to remove a section of his lung...
Third-Quarter Earnings Start This Week: Prepare for More Positive Surprises
By Louis Navellier Later this week, financial stocks will launch their third-quarter earnings season, and I expect most of the...
10 Most Anticipated Horror Games Coming Soon in 2026-2027
There is a bunching up of horror titles in the latter part of 2026 and the early months of 2027,...
Supreme Court to Hear Dispute Over Access to DOGE Records
By Matthew Vadum The Supreme Court on Oct. 13 agreed to decide whether a federal judge improperly ordered broad discovery...
Is Imperfect Women Season 2 Renewed?
Apple TV just dropped the most-awaited news for psychological thriller fans. Imperfect Women season 2 is happening. If you watched...